Boehringer Ingelheim
Hannes Koolman has a diverse background in pharmaceutical research, with extensive experience in medicinal chemistry. Hannes began their career at Merck KGaA as a PHD Researcher, focusing on drug development. Hannes then joined Sanofi as a Master-Student, further expanding their knowledge in the industry. Koolman went on to work at Abbott as a Postdoctoral Research Associate, where they conducted research and gained valuable experience. Hannes then transitioned to AbbVie, where they held the positions of Senior Scientist and Senior Scientist II, contributing to various scientific projects. Currently, Koolman is employed at Boehringer Ingelheim, serving as the Head of Antiparasitics Medicinal Chemistry, where they lead a chemistry team and oversees research projects in the animal health sector.
Hannes Koolman earned a Bachelor of Science in Chemistry from FAU Erlangen-Nürnberg in 2005. Hannes then went on to obtain a Master of Science in Medicinal and Pharmaceutical Chemistry from the same university from 2005 to 2007. Following this, they pursued a Doctor of Philosophy (PhD) in Organic Chemistry at Technische Universität Darmstadt from 2007 to 2010.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.